Forest gets rights to Gedeon Richter's antipsychotic
Forest Laboratories has licensed US and Canadian rights to Hungarian pharmaceutical company Gedeon Richter's RGH188 antipsychotic drug candidate and related compounds.
- Specialty Pharmaceuticals
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.